The impact of age on genetic testing decisions in amyotrophic lateral sclerosis
暂无分享,去创建一个
A. Al-Chalabi | P. Andersen | O. Hardiman | L. Ossher | K. Talbot | A. Mehta | P. Fratta | A. Iacoangeli | J. V. van Vugt | A. Al Khleifat | S. Opie-Martin | P. Mehta | Andrea Bredin | A. Bredin
[1] A. Al-Chalabi,et al. The importance of offering early genetic testing in everyone with amyotrophic lateral sclerosis , 2022, Brain : a journal of neurology.
[2] P. Andersen,et al. De novo mutations in SOD1 are a cause of ALS , 2021, Journal of Neurology, Neurosurgery, and Psychiatry.
[3] Ewout J. N. Groen,et al. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology , 2021, Nature Genetics.
[4] T. Jenkins,et al. Value of systematic genetic screening of patients with amyotrophic lateral sclerosis , 2021, Journal of Neurology, Neurosurgery, and Psychiatry.
[5] N. Pearce,et al. Motor Neuron Disease Register for England, Wales and Northern Ireland—an analysis of incidence in England , 2020, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[6] Timothy A. Miller,et al. Phase 1-2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS. , 2020, The New England journal of medicine.
[7] Annelot M. Dekker,et al. ATXN1 repeat expansions confer risk for amyotrophic lateral sclerosis and contribute to TDP-43 mislocalization , 2020, Brain communications.
[8] D. Burke,et al. A proposal for new diagnostic criteria for ALS , 2020, Clinical Neurophysiology.
[9] Melissa J. Landrum,et al. ClinVar: improvements to accessing data , 2019, Nucleic Acids Res..
[10] Ashley R. Jones,et al. C9orf72 intermediate expansions of 24–30 repeats are associated with ALS , 2019, Acta Neuropathologica Communications.
[11] A. Al-Chalabi,et al. Younger age of onset in familial amyotrophic lateral sclerosis is a result of pathogenic gene variants, rather than ascertainment bias , 2018, Journal of Neurology, Neurosurgery, and Psychiatry.
[12] O. Hardiman,et al. Determining the incidence of familiality in ALS , 2018, Neurology: Genetics.
[13] Ashley R. Jones,et al. Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trials , 2017, Neurology.
[14] A. Al-Chalabi. Perspective: Don't keep it in the family , 2017, Nature.
[15] Annelot M. Dekker,et al. Project MinE: study design and pilot analyses of a large-scale whole-genome sequencing study in amyotrophic lateral sclerosis , 2017, European Journal of Human Genetics.
[16] Ashley R. Jones,et al. ATXN2 trinucleotide repeat length correlates with risk of ALS , 2017, Neurobiology of Aging.
[17] Quan Li,et al. InterVar: Clinical Interpretation of Genetic Variants by the 2015 ACMG-AMP Guidelines. , 2017, American journal of human genetics.
[18] Chris Shaw,et al. Detection of long repeat expansions from PCR-free whole-genome sequence data , 2016, bioRxiv.
[19] F. Cunningham,et al. The Ensembl Variant Effect Predictor , 2016, bioRxiv.
[20] Bale,et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.
[21] C. Ki,et al. De novo FUS mutations in 2 Korean patients with sporadic amyotrophic lateral sclerosis , 2015, Neurobiology of Aging.
[22] N. Pearce,et al. Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study , 2014, The Lancet Neurology.
[23] Semyon Kruglyak,et al. Isaac: ultra-fast whole-genome secondary analysis on Illumina sequencing platforms , 2013, Bioinform..
[24] Olubunmi Abel,et al. ALSoD: A user‐friendly online bioinformatics tool for amyotrophic lateral sclerosis genetics , 2012, Human mutation.
[25] Bruce L. Miller,et al. Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS , 2011, Neuron.
[26] C. Lewis,et al. Modelling the Effects of Penetrance and Family Size on Rates of Sporadic and Familial Disease , 2011, Human Heredity.
[27] C. Shaw,et al. Amyotrophic Lateral Sclerosis/Motor Neuron Disease , 2006 .
[28] R. Durbin,et al. The Sequence Ontology: a tool for the unification of genome annotations , 2005, Genome Biology.
[29] E. Feuer,et al. Confidence intervals for directly standardized rates: a method based on the gamma distribution. , 1997, Statistics in medicine.
[30] A. Ludolph,et al. Amyotrophic lateral sclerosis. , 2012, Current opinion in neurology.
[31] A. Al-Chalabi,et al. Amyotrophic lateral sclerosis in an urban setting: a population based study of inner city London. , 2006, Journal of neurology.